Prediction of mortality in SSc-ILD depends on definition of ILD progression

被引：0

作者：

Hoffmann-Vold, Anna Maria ^{[1
]}

Petelytskab, Liubov ^{[2
]}

Fretheim, Havard ^{[1
]}

Barua, Imon ^{[1
]}

Becker, Mike ^{[2
]}

Bjorkekjaer, Hilde ^{[3
]}

Brunborg, Cathrine ^{[4
]}

Bruni, Cosimo ^{[5
]}

Diep, Phuong Phuong ^{[1
]}

Dobrota, Rucsandra ^{[5
]}

Durheim, Michael ^{[1
]}

Elhai, Muriel ^{[5
]}

Jordan, Suzana ^{[5
]}

Langballe, Emily ^{[1
]}

Midtvedt, Oyvind ^{[1
]}

Mihai, Carina ^{[5
]}

Molberg, Oyvind ^{[1
]}

Distler, Oliver ^{[5
]}

机构：

[1] Oslo Univ Hosp, Oslo, Norway

[2] Univ Hosp Zurich, Zurich, Switzerland

[3] Hosp Southern Norway, Kristiansand, Norway

[4] Oslo Univ Hopsital, Oslo, Norway

[5] Zurich Univ Hosp, Zurich, Switzerland

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA2914

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[31] Systemic Sclerosis - Role of the pulmonary microenvironment to drive SSc to SSc-ILD transition [J].

Viera, Rosa Rodriguez ;

Malitska, Julia ;

Sultani, Susan ;

Ainebyona, Alex ;

Chaudhuri, Nazia ;

Potel, Koray N. ;

Schock, Bettina C. .

IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 :S226-S227

[32] Dose adjustments in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) [J].

Kreuter, M. ;

Highland, K. B. ;

Kuwana, M. ;

Azuma, A. ;

Maher, T. ;

Mayes, M. D. ;

Raghu, G. ;

Girard, M. ;

Kohlbrenner, V ;

Clerisme-Beaty, E. ;

Alves, M. ;

Distler, O. .

PNEUMOLOGIE, 2020, 74 :S55-S56

[33] Natural variability in the disease course of SSc-ILD: implications for treatment [J].

Vonk, Madelon C. ;

Walker, Ulrich A. ;

Volkmann, Elizabeth R. ;

Kreuter, Michael ;

Johnson, Sindhu R. ;

Allanore, Yannick .

EUROPEAN RESPIRATORY REVIEW, 2021, 30 (159)

[34] New ways in the treatment of SSc-ILD: what makes sense? [J].

Kreuter, Michael ;

Hoffmann-Vold, Anna-Maria .

PNEUMOLOGE, 2019, 16 (05) :303-304

[35] Changes in FVC in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) [J].

Highland, Kristin B. ;

Azuma, Arata ;

Fischer, Aryeh ;

Kuwana, Masataka ;

Maher, Toby M. ;

Mayes, Maureen D. ;

Raghu, Ganesh ;

Girard, Mannaig ;

Alves, Margarida ;

Gahlemann, Martina ;

Distler, Oliver .

EUROPEAN RESPIRATORY JOURNAL, 2019, 54

[36] SERUM BIOMARKERS IN SSC-ILD: ASSOCIATION WITH PRESENCE, SEVERITY AND PROGNOSIS [J].

Stock, C. J. W. ;

Visca, D. ;

DeLauretis, A. ;

Daccord, C. ;

Kokosi, M. ;

Alfieri, V. ;

Kouranos, V. ;

Margaritopoulos, G. ;

George, P. M. ;

Molyneaux, P. L. ;

Chua, F. ;

Maher, T. M. ;

Ong, V. ;

Abraham, D. J. ;

Denton, C. P. ;

Wells, A. U. ;

Renzoni, E. A. .

THORAX, 2019, 74 :A56-A56

[37] Interstitial lung disease associated with systemic sclerosis (SSc-ILD) [J].

Cottin, Vincent ;

Brown, Kevin K. .

RESPIRATORY RESEARCH, 2019, 20 (1)

[38] THE PROGNOSIS INTERVALS FOR PTS WITH SSC-ILD USING DISCRIMINANT ANALYSIS [J].

Ovsyannikova, O. B. ;

Glukhova, S. ;

Koneva, O. ;

Lesnyak, V. ;

Ananieva, L. .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 :541-542

[39] New ways in the treatment of SSc-ILD: what makes sense? [J].

Kreuter, Michael ;

Hoffmann-Vold, Anna-Maria .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (09) :863-864

[40] Interstitial lung disease associated with systemic sclerosis (SSc-ILD) [J].

Vincent Cottin ;

Kevin K. Brown .

Respiratory Research, 20

← 1 2 3 4 5 →